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Plasmodium vivax and Plasmodium falciparum are becoming resistant to drugs including antifo-
lates,  sulphonamides and chloroquine. This study was focused at sequence analysis of
resistant genes of these parasites against sulphadoxine–pyrimethamine and chloroquine,
from  Bannu, Pakistan. Known mutations were detected at codons 57, 58 and 117 of pvdhfr
gene  of P. vivax, while none of the isolates had any pvdhps mutation. Similarly P. falciparum
isolates  exhibited double 59R + 108N mutations in pfdhfr, and single 437G in pfdhps thus
demonstrating  the existance of triple mutant 59R + 108N + 437G haplotype in this region. ThePlasmodium falciparum
Sequence  analysis
Pakistan
key chloroquine resistance mutation, 76T in pfcrt was observed in 100% of the P. falciparum
isolates,  with haplotype SVMNT which is also associated with resistance to amodiaquine.
Some  novel mutations were also observed in pvdhfr and pfdhfr genes.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDPlasmodium vivax and Plasmodium falciparum have been
reported to develop resistance against drugs like
sulphadoxine–pyrimethamine (SP) and chloroquine (CQ)
in  Pakistan.1 The development of multidrug resistance by
P.  falciparum and chloroquine resistance by P. vivax and
insecticide-resistant mosquitoes has led to major difﬁcul-
ties  in controlling the spread of malaria. Previous studies
have  suggested that resistance to SP is attributed to the
emergence of certain mutations that occur sequentially in
dihydropteroate synthase (dhps) and dihydrofolate reduc-
tase  (dhfr) genes of Plasmodium.2,3 Rigorous work has been
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Este é um artigo Open Access sob a licençaconducted to study the mutation structure of dhfr and dhps
genes  of P. falciparum but studies on P. vivax dhfr and dhps are
limited  to regions in Southeast Asia like Indonesia, Papua
New  Guinea, India and Sri Lanka.4,5
While PCR-RFLP methodologies have been developed for
the  detection of known polymorphisms, sequence analysis
enables  the detection of previously unknown mutations that
may  be playing some role in drug resistance.2 The sequencingabad 45320, Pakistan.
l.com (L. Khatoon).
approach is especially necessary for P. vivax, whose mecha-
nisms  of antimalarial drug resistance have not been clearly
deﬁned,  although thought to be similar to those of P. falciparum.
 de CC BY-NC-ND
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Table 1 – Sequence analysis of portions of Pvdhfr, Pvdhps, Pfdhfr, Pfdhps, Pfcrt, PfmdrI and dhfr genes of P. vivax and P.
falciparum parasites encompassing the regions with known drug resistant target-codons. P. vivax and P. falciparum
parasites were  obtained from blood samples of malaria patients from Bannu, Pakistan.
Genes Substitutions Samples Mutations Accessiona
Pvdhfr 149:A-T PK43, PK47, PK49, PK54, PK64 Q49H JN794518
172:A-C  PK100 S58R JN794521
174:C-G  PK42, PK68, PK76 S58R JN794517
174:C-A  PK66 S58R JN794520
205:T-C, 207:T-C PK60 Y69H JN794519
278,279:AG-CA PK11, PK36, PK58, PK86, PK87 S93Hb JN794515
350:G-A  PK25, PK30, PK34, PK42, PK43, PK46, PK47, PK49, PK54, PK57,
PK60, PK64, PK66, PK68, PK79, PK100, PK102
S117N  JN794516
Pvdhps Wild typec JN794522
Pfdhfr 175:T-C PK1, PK4, PK6, PK7, PK8, PK10, PK19, PK53, PK55, PK63, PK71,
PK74, PK85, PK101, PK105, PK106, PK108, PK109, PK110, PK111,
PK112
C59R JN794523
323:G-A  PK1, PK4, PK6, PK7, PK8, PK10, PK19, PK53, PK55, PK63, PK71,
PK74, PK85, PK101, PK105, PK106, PK108, PK109, PK110, PK111,
PK112
S108N
493:G-A PK1, PK4, PK5, PK6, PK7, PK8, PK10, PK19, PK41, PK53, PK55,
PK63, PK74, PK85, PK101, PK109
G165Rb
Pfdhps 69:C-G PK6, PK63, PK85, PK109, PK112 A437G JN794524
PfmdrIa 230:A-T PK53, PK72, N86Y JN794525
PfmdrIb Wildc JN794526
Pfcrt 87:T-A95,96:TG-GA98:A-T PK1, PK5, PK6, PK53, PK112 K76T
a Could not be submitted to GenBank due to short sequence size (≤200 bp).
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7b Novel mutation.
c Mutation observed in one or two isolates were ignored and hence r
This study is an extension of our previous study6 where
rug  resistance has been studied through PCR-RFLP. The objec-
ive  was  to know the overall gene sequence of P. falciparum and
.  vivax isolates from Bannu district in Pakistan; a region with
igh  prevalence of malaria, but where molecular studies of
alaria  parasites are particularly scarce.
As described earlier,6 two samples from patients infected
ith  P. falciparum, 69 carrying P. vivax and 26 having mix
nfection  were  sequenced to analyze the frequency of drug
esistance  mutations. Sequence analyses was  conducted at
he Pfcrt, Pfdhfr, Pfdhps, PfmdrI, Pvdhfr, and Pvdhps genes using
rimers  already published that allow to amplify fragments
ncompassing several codons in each gene.2,7–9 A total of 160
enes  were  cloned and sequenced consisting 10 Pfcrt, 23 Pfdhfr,
2  Pfdhps, 20 PfmdrI spanning codon 86 and 10 PfmdrI spanning
odons  1042 and 1246; 40 Pvdhfr, and 35 Pvdhps. Each fragment
as  cloned using the TA cloning kit (Invitrogen) according to
anufacturer’s instructions. Bioedit and CLC DNA online soft-
ares were  used to investigate the phylogenetic relationships
mong  the fragments of the genes analyzed.
Table 1 summarizes the single nucleotide polymorphisms
SNPs) detected in the studied genes. 711 bp of the pvdhfr gene
equence  spanning codons 13, 33, 57, 58, 61, 117 and 173
ere  compared with the sequence of gene with a P. vivax iso-
ate  collected from Pakistan (GenBank accession no. X98123.1).
ovel  mutations were conﬁrmed after sequencing at least two
lones for each fragment. The majority of single nucleotide
olymorphisms (SNPs) led to synonymous changes, with few
xceptions  (Table 1). A change from A to T at position 149
esulted  in the substitution of a Q for an H in 12.5% of the
amples.  Similarly, two adjacent SNPs at positions 77 and
8  resulted in the emergence of a novel mutant type S93H.ed as wild type.
Similarly,  we found a mutation of two nucleotides at positions
278  and 279 leading to S93H mutation in 16.5% of the P. vivax
samples.  However, the role of these mutations in conferring
resistance against SP is still to be explored. Compared to the
wild  type reference, 17.5% of samples showed an insertion
or  deletion of an 18 bp fragment (ACACACGGTGGTGACAAT)
which was  not taken into consideration during nucleotide
count). Phylogenetic tree in Fig. 1A shows that 7 clusters of pvd-
hfr were obtained. Sample PK11 is closely related to the wild
type  strain shown as pvdhfr in the ﬁgure. However, it has less
similarity  with other isolates. 705 bp region of pvdhps gene was
sequenced  and compared with wild type isolate from GenBank
(accession  no. AY186730.1). There was  no change at codons 383
and 553.
Sequences of Pfdhfr gene spanning codons 16, 50, 51, 59,
108  and 164 were compared with GenBank sequence (acces-
sion  no. J04643.1). Sequence homology among these isolates
is  represented by the neighbor joining phylogenetic tree in
Fig.  1B. Sequence variation at pfdhps locus was  determined by
comparing sequence data of samples with wild type isolate
from  GenBank (accession no. Z30659.1). In 31.8% of the iso-
lates,  a SNP at position 69 led to the mutation A437G. A 145 bp
region  of the pfcrt gene was  compared with GenBank wild type
isolate  (accession no. AF030694.2) and it was found that all
the  samples carried SVMNT haplotype. The sequence data
of  the pfmdrI gene were compared with wild type sequence
from  GenBank (accession no. X56851.1). All samples carrying
any  non-synonymous mutation and a representative wild type
sequences were  submitted to the GenBank (Table 1).
This  study was  aimed at sequencing the entire genes
involved in drug resistance to ﬁnd out the involvement of any
possible  new mutations in conferring drug resistance. Though
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it has been found earlier that SP drug resistance is prevalent
in  Bannu and PCR-RFLP showed some known mutations,6 to
have  the genetic picture of the organisms it was  important
to  sequence the entire genes. So our aim was  to identify the
level  of polymorphism and possibly new mutations that need
to  be studied further in order to assess their implication on
clinical  efﬁcacy of SP. SP is effective in patients having P. vivax
infection  with wild-type genotype or even a 58R-117N dou-
ble  mutant allele10 so other mutations are clearly involved.
Sequence analysis showed polymorphism in this gene and
some  unique mutations like Q49H, Y69H and S93H have alsodhfr (B) along with wild type sequences from GenBank.
been  found but their role in conferring drug resistance against
SP  is still to be elucidated.
No  pvdhps mutation was  detected in isolates from our study
area.  Therefore, it can be said that Bannu is an area where SP
pressure  in low, similar to earlier ﬁndings.9
Mutations in pfdhfr gene are said to emerge in a stepwise
manner4 with S108N emerging initially followed by N51I or
C59R  and lastly I64L mutant type. By comparison we  observed
mutations at codons 59 and 108 in all our isolates but no muta-
tion  was observed at codons 51. McCollum and colleagues
while working with African isolates opposed this theory by
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fnding 51I/108N/164L genotype.11 We  did not ﬁnd A16V and
108T  mutations that are thought to be responsible for resis-
ance  against the drug Cycloguanil which again support the
ndings  of Garg and colleagues.12 A non-synonymous muta-
ion  G165R was  detected in pfdhfr gene which to our knowledge
s  a novel mutation.
The  majority of isolates were  found to contain wild-type
fdhps gene.
We  detected haplotype 86Y-1042Y, in Pfmdr1 gene unlike in
est  Africa where 86Y-86N-1246D haplotype occurred more
ommonly.13 Mayengue and colleagues while working with
solates  from Gabonese patients found Pfmdr1 86Y and 184F
utations  in their samples which are in accordance with our
ndings  though we  did not analyze mutations at codon 184.14
We  found haplotype SVMNT in all our isolates which is also
ound  in isolates from Papua New Guinea and South America.
he  SVMNT haplotype of pfcrt is also considered to be linked
ith  chloroquine resistance, and, like the K76T mutation, it is
ommon among Indian ﬁeld isolates15 which is in accordance
ith  our ﬁndings. CVIET haplotype is more  prevalent in Asia
nd  Africa while SVMNT is associated with Papua New Guinea
nd  South American isolates16 while SVIET, CVIKT, CVIDT and
VTNT  have been found in Southeast Asia.17 High level of
utation  in pfcrt gene shows that P. falciparum has developedesistance against CQ. It could be due to the fact that areas
ike  Pakistan where mixed infections by both P. vivax and P.
alciparum  exist and CQ is prescribed for treatment of P. vivaxmalaria thus inadvertently putting P. falciparum under selec-
tive  drug pressure which leads to emergence of CQ resistance,
as  observed in the Mekong Delta.18
In this study, sequence analysis of key genes asso-
ciated with antimalarial drug resistance showed that P.
falciparum  and P. vivax in the Bannu district of Pakistan have
not  yet reached an alarming threshold against drugs like
sulfadoxine–pyrimethamine unlike in many  parts of the world
but  resistance seems to be on the rise. However, P. falciparum
seem  to have already acquired considerable resistance against
CQ.  Moreover, some novel mutations, whose roles in malaria
drug  resistance are unknown, were  identiﬁed.
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